Autologous point-of-care stromal vascular fraction transplantation in dogs with advanced osteoarthritis of the knee and hip joints

Aust Vet J. 2024 Jan-Feb;102(1-2):41-46. doi: 10.1111/avj.13303. Epub 2023 Dec 4.

Abstract

Objective: The aim of the study was to assess lameness in dogs with advanced osteoarthritis of the hip and knee joints after a single autologous point-of-care transplantation of the Stromal Vascular Fraction (SVF) into the affected joint.

Materials and methods: During a minilaparotomy, 10 g of falciform fat was removed from each patient for each joint to be treated. A modern and time-saving procedure (ARC TM System, InGeneron GmbH, Houston, USA) was used for the in-house preparation of the SVF, so that the isolated cells could be applied to the respective joint within 2 h after fat removal. In total, five knee joints of five patients and seven hip joints of four patients were treated.

Results: Improvement in lameness according to owner questionnaires was seen in 3 of 5 patients with knee joint arthritis and 2 of 4 patients with hip joint arthritis. Based on gait analysis, only one dog with gonarthrosis and one dog with coxarthrosis showed improvement up to a maximum of 3 months after surgery.

Conclusion: This is the first case series on the treatment of osteoarthrosis of the knee or hip joint using point-of-care transplantation of the SVF. In individual cases, this method may represent a therapeutic approach for the treatment in dogs with advanced cox- or gonarthrosis, although only a short-term effect can be expected, which calls into question the effort and costs involved.

Keywords: centrifuge; coxarthrosis; dogs; gonarthrosis; point of care; regenerative cells.

MeSH terms

  • Animals
  • Dog Diseases* / surgery
  • Dogs
  • Hip Joint / surgery
  • Knee Joint
  • Lameness, Animal
  • Osteoarthritis, Hip* / surgery
  • Osteoarthritis, Hip* / veterinary
  • Osteoarthritis, Knee* / surgery
  • Osteoarthritis, Knee* / veterinary
  • Point-of-Care Systems
  • Stromal Vascular Fraction

Grants and funding